The treatment works just as well for women with light skin as it does for women with dark skin — skin color doesn’t make a difference in how well it works.
Scientific Claim
The efficacy of CCH-aaes for buttock cellulite is not significantly affected by Fitzpatrick skin type, with similar rates of ≥2-level composite response observed across all skin tone categories from I to VI.
Original Statement
“Subgroup analyses indicated no apparent impact of Fitzpatrick skin type category and baseline cellulite severity (moderate/severe) on CCH-aaes efficacy... Numeric trends favoring CCH-aaes versus placebo were observed across the subgroups analyzed, including no differences in response to CCH-aaes treatment in women with a lighter skin type (FST category I–III) versus a darker skin type (FST category IV–VI).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The RCT design with subgroup analysis and no significant difference in response rates allows the conclusion that skin type does not affect efficacy. The phrase 'no apparent impact' is appropriately cautious and supported by data.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aIn EvidenceConsistent lack of skin-type-dependent efficacy across diverse populations.
Consistent lack of skin-type-dependent efficacy across diverse populations.
What This Would Prove
Consistent lack of skin-type-dependent efficacy across diverse populations.
Ideal Study Design
A systematic review and meta-analysis of all RCTs of CCH-aaes for cellulite, stratifying ≥2-level composite response by Fitzpatrick skin type (I–VI), with subgroup analysis and statistical interaction testing across ≥1500 patients.
Limitation: Cannot assess long-term outcomes or rare adverse events by skin type.
Randomized Controlled TrialLevel 1bIn EvidenceCausal equivalence of CCH-aaes efficacy across skin types.
Causal equivalence of CCH-aaes efficacy across skin types.
What This Would Prove
Causal equivalence of CCH-aaes efficacy across skin types.
Ideal Study Design
A double-blind RCT of 600 adult women with moderate-to-severe buttock cellulite, stratified by Fitzpatrick skin type (I–VI), randomized to CCH-aaes or placebo, with primary endpoint being ≥2-level composite response at Day 71, powered for subgroup interaction.
Limitation: Limited to buttock cellulite; does not assess efficacy on other body areas.
Prospective Cohort StudyLevel 2bReal-world effectiveness across skin types in diverse clinical settings.
Real-world effectiveness across skin types in diverse clinical settings.
What This Would Prove
Real-world effectiveness across skin types in diverse clinical settings.
Ideal Study Design
A prospective cohort study of 1000 women treated with CCH-aaes for buttock cellulite across multiple ethnicities and skin tones, measuring composite response at 71 days and patient satisfaction stratified by Fitzpatrick type.
Limitation: No control group; potential for confounding by provider technique or cultural bias.
Cross-Sectional SurveyLevel 4Association between skin tone and perceived treatment success in real-world users.
Association between skin tone and perceived treatment success in real-world users.
What This Would Prove
Association between skin tone and perceived treatment success in real-world users.
Ideal Study Design
A cross-sectional survey of 500 women who received CCH-aaes, asking for self-reported improvement and Fitzpatrick skin type, with objective photographic review by blinded assessors.
Limitation: Cannot establish causation; subject to recall and reporting bias.
In Vitro StudyLevel 5Biological plausibility of collagenase activity being unaffected by melanin content.
Biological plausibility of collagenase activity being unaffected by melanin content.
What This Would Prove
Biological plausibility of collagenase activity being unaffected by melanin content.
Ideal Study Design
An in vitro study comparing collagenase activity on human dermal collagen matrices derived from skin samples of Fitzpatrick I–VI donors, measuring collagen degradation rate and enzymatic kinetics.
Limitation: Cannot replicate in vivo tissue architecture, immune response, or adipose interactions.
Evidence from Studies
Supporting (1)
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
The study found that the cellulite treatment works just as well for women with light, medium, or dark skin — skin color didn’t make a difference in how well it worked.